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Novel collagen glomerulopathy in a homotrimeric type I colla- disease, culminating in glomerulosclerosis and renal fail-
gen mouse (oim). ure [1–3]. Excess extracellular matrix (ECM) production
Background: Oim/oim mice [osteogenesis imperfecta model; has been hypothesized to result from over compensationhomozygous null for the pro2(I) collagen gene] synthesize
of the glomerular wound healing response [4, 5]. Thoughexclusively the homotrimeric type I collagen isotype, 1(I)3,
much is known about the progression of kidney fibrosisand are unable to synthesize the normal heterotrimeric type I
collagen isotype, 1(I)22(I). Previous studies of the oim/oim and glomerulosclerosis, very little is known mechanisti-
mouse have focused on the musculoskeletal system, with no cally about the role of the ECM in the pathogenesis of
systematic evaluation of other organ systems. the mesangial cell response. We present in this reportMethods: Multiple tissues from oim/oim, oim/ (heterozy-
the identification and characterization of a novel type Igous) and / (wild-type) mice were examined for gross and
histological abnormalities. Tissues were stained with (1) hema- collagen glomerulopathy in the oim mouse.
toxylin and eosin (to assess lesion formation), (2) picrosirius Type I collagen is the predominant structural protein
red (collagen content), and (3) periodic acid methenamine in many tissues, and abnormalities in type I collagen
silver (basement membrane). Kidneys were further evaluated
synthesis and structure are associated with many inher-ultrastructurally by electron microscopy and immunohisto-
ited and acquired connective tissue disorders [6–10]. Thechemically with anti-1(I) and anti-1(III) collagen antibodies.
Results: Histological analyses revealed accumulations of pi- predominant isotype of type I collagen present in tissue
crosirius red-positive material, consistent with collagen, in glo- is the heterotrimeric molecule, composed of two 1(I)
meruli of 28/29 oim/oim mice, with no evidence of mesangial chains and one similar, but genetically distinct 2(I)cell proliferation. Only the most severely affected animals had
chain [6, 11]. The homotrimeric isotype consisting ofevidence of increased capillary basement membrane thickening
three 1(I) chains, 1(I)3, has been shown to naturallyor mild inflammation around the affected glomeruli. Electron
microscopy confirmed the presence of fibrillar collagen. Immu- occur in low levels in normal adult skin, during embry-
nohistochemistry with anti-1(I) collagen antibodies confirmed onic development, and during wound healing [11–14].
accumulation of type I collagen in the oim/oim glomeruli. The
The 1(I) and 2(I) collagen chains are synthesized as/ and oim/ kidneys had normal mesangium with no evi-
precursor procollagen chains, which assemble into ma-dence of infiltration of collagenous material.
Conclusions. This study demonstrates the first evidence, to ture collagen fibrils after a complex series of co- and post-
our knowledge, of abnormal glomerular collagen deposition translational processing steps [6, 11]. Specific domains
associated with a type I collagen defect. Further in vivo and in the 2(I) and 1(I) chains have been identified thatin vitro studies are necessary to elucidate the mechanistic,
regulate fibril assembly [15–18].functional, and pathological significance of the oim/oim colla-
In the normal glomerulus of the kidney there are threegen glomerulopathy.
cell types: mesangial, epithelial, and tubular cells [5].
Mesangial cells compose 30 to 40% of the total glomeru-
Progressive accumulation of collagen in the glomeru- lar cells. The kidney normally has very little type I or
lar mesangial matrix is a major factor in chronic renal type III collagen, and its presence is generally associated
with severe disease states [19–21]. In contrast to the
intact kidney, cultured mesangial cells have been shown
Key words: extracellular matrix, mesangium, pro2(I)collagen, trans-
to produce type I and lesser amounts of types III, IVgenic mouse model, chronic renal disease, renal failure, glomeruloscle-
rosis. and V collagens [4, 5, 22, 23]. For this reason mesangial
cell cultures are thought to mimic the collagen phenotypeReceived for publication August 9, 2001
of diseased glomeruli.and in revised form February 7, 2002
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Table 1. Age of mice examined for histologic lesions of the kidneyand are unable to synthesize functional pro2(I) collagen
chains [24, 25]. Thus, in the absence of pro2(I)collagen Number of animals examined
chains the oim/oim synthesize exclusively the homotri- Age oim/oim oim/ /
meric isotype of type I collagen, 1(I)3. The oim/oim 3–4 months 13 3 0
mice are phenotypically similar to humans with moder- 4–5 months 7 4 5
5–6 months 3 4 5ately severe osteogenesis imperfecta (OI), characterized
6–12 months 5 2 7by severe skeletal fragility and deformity.
12 months 1a 2b 1c
Previous studies of the oim/oim mouse have focused
a oim/oim mouse was 25-months-old
on the musculoskeletal system [26–34], but no systematic b oim/ mice were 25- and 30-months-old
c/ mouse was 13-months-oldevaluation of other organ systems has been performed.
In this study, multiple tissues from oim/oim, oim/ (het-
erozygous) and/ (wild-type) mice were examined for
gross and histological abnormalities. These examinations
Sections from select kidneys also were stained with pi-
revealed a previously unrecognized renal abnormality in
crosirius red to assess collagen deposition, periodic acid
the oim/oim mice. Presented here are the histological,
Schiff or periodic acid methenamine silver to assess base-ultrastructural, and immunohistochemical features of a
ment membrane morphology, and alcian blue to assessnovel type I collagen glomerulopathy in the oim/oim
proteoglycan content. Picrosirius red-stained sectionsmice.
were examined by conventional light microscopy as well
as with polarized light. Glomerular lesions scores were
METHODS determined from H&E-stained sections using the follow-
ing scale: 0  no lesions; 1 mild lesions, less than 50%Animals
of glomeruli affected; 2  moderate lesions, less thanHomozygous B6C3Fe-a/a-Cola2oim/oim (oim/oim), het-
50% of glomeruli affected; 3  moderate lesions, moreerozygous (oim/) and wild-type (/) mice were pur-
than 50% glomeruli affected; 4  severe lesions, morechased from the Jackson Laboratory (Bar Harbor, ME,
than 50% of glomeruli affected.USA) [24]. All animals were housed in an AAALAC
accredited facility, provided water and food (standard Morphometry
laboratory diet consisting of autoclavable rodent labora-
To estimate the amount of glomerular collagen deposi-tory chow, 5010; Purina Mills Inc., Richmond, IN, USA)
tion, picrosirius red-stained kidneys from 19 oim/oimad libitum, and handled according to an approved Uni-
mice were examined under polarized light and threeversity of Missouri Animal Care and Use protocol. Oim/
adjacent 200 views of the renal cortex were selectedoim, oim/ and/ genotypes were confirmed by poly-
for imaging. Images were captured with an Olympusmerase chain reaction-restriction fragment length poly-
BX-60 digital camera, converted to tiff images in Adobemorphism (PCR-RFLP) analysis [31].
Photoshop 5.5 (Adobe Systems Incorporated) and ana-
lyzed using the Scion Image for Windows program (ScionHistology
Corporation, Frederick, MD, USA). Perivascular re-As a pilot study, seventeen different tissues (including,
gions were deleted and total area occupied by collagenheart, liver, lung, kidney, spleen, intestine, and brain)
was calculated using the threshold mode. Glomerularfrom six oim/oim, one oim/ (heterozygous) and two
collagen deposition was estimated by dividing collagen/ (wild-type) mice were examined for gross and histo-
area by the number of glomeruli in that field.logical abnormalities. These examinations revealed a
previously unrecognized renal abnormality in the oim/
Electron microscopyoim mice described herein. Kidneys were subsequently
Mice (oim/oim, N  2; /, N  2) were euthanizedcollected for histologic examination from an additional
and kidneys were perfused with 0.9% NaCl (2 min),23 oim/oim (29 total), 14 oim/ (15 total) and 16 /
followed by neutral 1.25% glutaraldehyde in 0.1 mol/L(18 total) mice. Female mice were euthanized and per-
cacodylate buffer (3 min). Sections were prepared asfused (112 mm Hg, a pressure that mimics the normal
described [35].oim/oim mouse systolic pressure) via the left ventricle
or the abdominal aorta with 0.9% NaCl, followed by
Immunohistochemistry for 1(I) and 1(III) collagenneutral buffered 10% formalin for histological evalua-
To determine if the fibrillar collagens, type I and typetions. Multiple ages of mice, ranging from 3 to 25 months,
III were present, kidneys were evaluated by immunohisto-were examined (Table 1). All kidneys were sectioned
chemistry of paraffin-embedded sections. Heat-inducedlongitudinally and processed routinely for histologic ex-
epitope retrieval in 0.1 mol/L citrate buffer was per-amination. Five-micrometer sections were stained with
hematoxylin and eosin (H&E) and examined for lesions. formed in a vegetable steamer. Endogenous peroxidase
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was removed by treating slides with 3% hydrogen perox- ings included capillary wall thickening, capsular adhe-
sion, hyperplasia of parietal epithelial cells and crescentide and non-specific antibody binding was blocked with
formation, thickening of capsule basement membrane,a 5% bovine serum albumin (BSA) solution. Immunohis-
periglomerular fibrosis and mononuclear cell inflamma-tochemistry was performed using rabbit polyclonal anti-
tion. However, in mild-to-moderately affected glomerulicollagen type I primary antibody (LF-67; provided by
none of these findings were evident, suggesting that colla-L.W. Fisher [36]) diluted 1:100 in 5% BSA, a rabbit anti-
gen deposition was the primary lesion. Twenty-eight ofcollagen type III primary antibody (a kind gift from
29 oim/oim mice evaluated developed glomerular lesionsG. Kostka) diluted 1:500, a biotinylated anti-rabbit IgG
with some degree of collagen deposition. The amountsecondary antibody diluted 1:200, a horseradish peroxi-
of glomerular collagen deposition also was estimated bydase-labeled avidin conjugate, a 3,3diaminobenzidine
morphometric analyses. The glomerular area occupiedtetrahydrochloride (DAB) substrate and hematoxylin
by collagen ranged from 2155 m2 in the oim/oim mousecounterstain. Staining was performed on an automated
with no lesions to 38,372 m2 in an oim/oim mouse withimmunostainer (NexES; Ventana Medical Systems, Inc.,
a lesion score of 4. As expected, there was a positiveTucson, AZ, USA).
correlation (r  0.743; P  0.01) between lesions scores
Statistics and glomerular collagen deposition (Fig. 2). Curiously,
neither lesion scores (data not shown) nor collagen depo-To measure the strength of association between age,
sition increased significantly as mice aged (Fig. 3). Selectlesion score and glomerular collagen deposition, the
kidneys were stained also with alcian blue (pH 1 andSpearman Rank Order Correlation test in the statistical
pH 2.5) to assess proteoglycan content; no difference wassoftware package, SigmaStat (SPSS, Inc., Chicago, IL,
evident in the proteoglycan content (data not shown). NoUSA) was used.
glomerular lesions were seen in oim/ (not shown) or
/ mouse kidneys (Fig. 1).
RESULTS The presence of fibrillar collagen in the oim/oim mes-
Previous studies of the oim mouse by our laboratory angium was confirmed by electron microscopy (Fig. 4).
and others have focused on the musculoskeletal system Wild-type mouse kidneys had normal mesangium, with
[26–34], and until now no systematic evaluation of other no evidence of infiltration. The oim/oim mesangium was
expanded 2 to 3 times, with infiltration by moderatelyorgan systems has been performed. To evaluate the ef-
electron-dense granular and fibrillar material. Many offect of the presence of homotrimeric type I collagen
the deposits showed clear fibrillar organization with bun-[absence of pro2(I)collagen] we systematically exam-
dles of fibrils, demonstrating the typical cross striationined multiple organ systems from oim/oim (homozy-
pattern of organized collagen, which appears consistentgous), oim/ (heterozygous), and/ (wild-type) mice.
with the striation patterns of oim/oim homotrimeric typeSeventeen different tissues were examined (heart, brain,
I collagen previously reported [37]. The glomerular base-liver, lung, kidney, spleen, stomach, duodenum, jejunum,
ment membranes in both oim/oim and/ kidneys wereileum, cecum, colon, salivary glands, uterus, ovary, quad-
unremarkable and the epithelial foot processes were in-riceps muscle, and urinary bladder) from oim/oim (N 
tact.6), oim/ (N  1), and / (N  2) mice for gross and
To determine if the fibrillar collagen was composedhistological abnormalities. Except for lesions in the oim/
of type I collagen and/or type III collagen, kidneys wereoim kidney, no significant gross or histological lesions
evaluated immunohistochemically. Serial sections of kid-were seen. Kidneys were subsequently collected for his-
ney from a / mouse, an oim/oim mouse with a lesiontologic examination from an additional 23 oim/oim (29
score of 1 and an oim/oim mouse with a lesion scoretotal), 14 oim/ (15 total) and 16 / (18 total) mice.
of 4 were treated with LF-67 polyclonal anti-pro1(I)Histological examination of oim/oim mouse kidneys re-
collagen antibodies, polyclonal anti-pro1(III) collagenvealed accumulation of homogenous material in the glo-
antibodies, or control serum. Polyclonal anti-pro1(I)merular tufts. This material was determined to be colla-
collagen antibodies demonstrated that the accumulatedgen on picrosirius red-stained sections (Fig. 1). No
collagen in the oim/oim glomeruli consisted of type I colla-
evidence of increased collagen deposition was observed
gen (Fig. 5). There was no evidence of type III collagen
in other parts of oim/oim mouse kidneys including blood in the glomeruli of either oim/oim and / kidneys;
vessels, perivascular spaces and interstitium. Lesion se- positive perivascular collagen staining served as an inter-
verity was scored on the following scale: 0  no lesions; nal positive control (not shown).
1  mild lesions, less than 50% of glomeruli affected;
2  moderate lesions, less than 50% of glomeruli af-
DISCUSSIONfected; 3  moderate lesions, more than 50% glomeruli
affected; 4 severe lesions, more than 50% of glomeruli Previous investigations of the oim/oim mouse have
focused primarily on the musculoskeletal system with noaffected. In severely affected glomeruli, additional find-
Fig. 1. Histological examination revealed accumulations of picrosirius red-positive material, consistent with collagen, in the glomeruli of oim/oim
mice, which was not present in / mouse kidneys. Histology of serial kidney sections of wild-type (/; A, B, C, D), mildly affected oim/oim
(score of 1; E, F, G, H), and severely affected oim/oim (score of 4; I, J, K, L) mice stained with hematoxylin and eosin (A, E, I), periodic acid
methenamine silver (B, F, J) and picrosirius red (C, G, K, non-polarized; D, H, L, polarized), at 200 magnification. The / mouse kidneys
had normal mesangium, with no evidence of infiltration by abnormal material.
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Fig. 2. Correlation between the amount of collagen deposited in glo- Fig. 3. Correlation between the amount of collagen deposited in oim/
meruli of the oim/oim mice and their lesion score. There was a positive oim mice glomeruli and age of the mouse. There was no significant
correlation (r  0.743) between these two variables (Spearman’s rank relationship between these two variables (Spearman’s rank correlation
correlation test; P  0.01). test).
stage renal disease, regardless of the origin [1–3, 5, 20,systematic evaluation of other organ systems. Our study
demonstrates the first evidence, to our knowledge, of 44]. The predominant collagens associated with second-
ary collagen glomerulosclerosis and glomerular fibrosisabnormal collagen accumulation in the glomeruli associ-
ated with a type I collagen defect. Furthermore, this are most often type IV collagens, then type III collagen,
and generally only when it is very severe disease is typereport provides evidence that exclusive expression of
homotrimeric type I collagen may be detrimental to kid- I collagen present [20, 44]. Yoshioka et al demonstrated
in vivo that types III and I collagen often co-existedney morphology.
Hereditary renal diseases are responsible for 16% of within nearly or totally sclerosed glomeruli, while type
III collagen without type I collagen was present in mod-chronic renal failure in children [38]. Alport syndrome
is the best known of the hereditary collagen defects, erately severe glomeruli [20].
Normally, the in vivo kidney has very little if any typewhich results from defects in type IV collagen, a non-
fibrillar collagen and a primary component of the base- I or type III collagen present, and its presence is generally
associated with disease states [19–21]. In contrast, colla-ment membrane [39]. Direct association of kidney disor-
ders with fibrillar collagen defects only recently has been gen expression by cultured mesangial cells (in vitro) is
very different. Because mesangial cells in culture pro-reported with type III collagen, though the exact etiology
for the over-expression of type III collagen is unknown duce collagen, mainly type I, and to a lesser amount
types III, IV, and V collagens, they are hypothesized to[40–43]. This type III collagen glomerulopathy appears
to be autosomal recessive, and is characterized by a dif- mimic the collagen phenotype of diseased glomerulus
[4, 22].fuse increase in glomerular mesangial matrix and widen-
ing of capillary walls and in some cases progresses to It is controversial as to whether the type I collagen
present in vitro or in vivo is homotrimeric or heterotrim-renal failure [40–43]. Some patients develop hyperten-
sion, hemolytic anemia, and pulmonary disease as well. eric type I collagen. Studies by Haralson, Jacobson and
Hoover have demonstrated synthesis of both homotri-Electron microscopy confirmed fibrillar collagen was in
the mesangial matrix and it was subsequently determined meric and heterotrimeric isotypes of type I collagen in
cultured (in vitro) normal rat glomerular mesangial cellsby immunohistochemistry to be primarily type III colla-
gen and to a lesser extent type I collagen (localized [4], whereas Ohyama et al reported only finding the
heterotrimeric isotype [22]. Haralson et al’s findings sug-primarily to the peripheral wall) [41, 43].
Though primary human collagen glomerulopathies gest that only half of newly synthesized collagen is re-
leased into the media, and the predominant type I colla-have been described [39], it is the secondary collagen
glomerulosclerosis and glomerular fibrosis that are much gen isotype in the cell layer was homotrimeric type I
collagen. Ohyama et al also found type I collagen in themore prevalent and a common manifestation in end-

Fig. 5. Immunohistochemistry using polyclonal anti-pro1(I) collagen antibodies (LF-67) demonstrate the accumulated collagen in the oim/oim
mesangium consists of type I collagen. Serial kidney sections of a wild-type mouse (A, B) and an oim/oim mouse with a lesion score 4 (C, D)
were treated with LF-67 polyclonal anti-collagen type I antibodies (A, C) or control serum (B, D), at 200 magnification. Specific collagen staining
was evident in glomeruli of oim/oim mice.
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Fig. 4. Electron microscopy confirmed the
presence of fibrillar collagen. The mesangium
of the oim/oim glomeruli was expanded by 2 to
3 times, with infiltration by moderately electron
dense granular and fibrillar material, which
exhibited typical cross-striation of organized
collagen. (A) Magnification (9600) of an
oim/oim glomerular mesangial cell (*indicates
nucleus) demonstrating extracellular deposits
with clear fibrillar organization and bundles of
fibrils (arrows). (B) Magnification (18,700) of
a fibrillar deposit demonstrates typical cross
striation of organized collagen (arrows). The
epithelial foot processes were intact for both
oim/oim and wild-type mice.
cultured mesangial cell layer, however, it was only the brils. Both amino- and carboxy-propeptides have been
shown to have feedback inhibitory effects on collagenheterotrimeric isotype. These conflicting reports may be
attributed to variations in the culturing conditions or synthesis [15–17]. The carboxy-propeptide pre-transla-
tionally regulates collagen synthesis by internalizing andpossibly to mesangial cells, which may have dedifferenti-
ated to the extent to result in reduced 2(I) expression. going into the nuclear compartment to down-regulate
procollagen gene transcription [16]. Prockop and FertalaThe accumulation of type I collagen in oim/oim mouse
glomeruli suggest that homotrimeric type I collagen is demonstrated that a nine amino acid peptide from the
2(I) collagen telopeptide (end of the triple helix andunder different regulatory control mechanisms than het-
erotrimeric type I collagen, and may provide a unique retained by the mature collagen) was sufficient to inhibit
collagen fibril assembly [18], supporting the hypothesisopportunity to investigate mechanisms of kidney damage
and fibrosis. that 2(I) collagen may have regulatory role in normal
fibrillar formation and assembly. The major physiologi-Though the pathological significance of accumulated
homotrimeric type I collagen in the mesangium of the cal regulators of ECM degradation in the glomerulus are
matrix metalloproteinases (MMP) [47]. High rates ofglomerulus of oim/oim mice remains to be determined,
it is perhaps analogous to the isotype alterations seen ECM turnover are characterized by renal disease and
during normal renal development. Perhaps the metallo-in Alport syndrome [39, 45, 46]. Alport syndrome, a
hereditary disorder characterized by progressive ne- proteinases differentially regulate and/or have differen-
tial specificity to homo- and heterotrimeric type I colla-phropathy, results from defects in either pro3(IV),
pro4(IV) or pro5(IV) collagen genes [39]. The nor- gen. Future studies are necessary to determine the
pathogenesis of collagen deposition in the oim/oimmal adult glomerular basement membrane is composed
of type IV collagen networks of predominantly the mouse.
Transgenic mouse models may provide clues to the3(IV)4(IV)5(IV) type IV collagen isotype, and the
1(IV)22(IV) type IV collagen isotype [39, 45, 46]. In mechanisms involved in this collagen glomerulopathy
[48–53]. Chatziantoniou et al describe the treatment ofthe glomerular basement membranes of Alport syn-
drome patients the 3(IV)4(IV)5(IV) isotype is se- transgenic mice harboring the luciferase gene under the
control of the murine pro2(I)collagen promoter withverely reduced or absent. The altered composition of
their glomerular basement membranes is hypothesized the nitric oxide synthesis inhibitor L-NAME (NG-nitro-
l-arginine-methyl ester), which resulted in the synthesisto reflect failure of an early developmental switch; the
fetal 1 and 2 chains persist in the adult glomerular and deposition of type I collagen in the afferent arterioles
and glomeruli [48]. The fibrosis appeared to be in partbasement membranes and are not replaced by 3, 4
and 5 chains [45, 46]. mediated by endothelin-induced activation of type I col-
lagen expression, and independent of the L-NAME in-Accumulation of extracellular matrix can occur as a
result of increased synthesis, decreased degradation, or duction of hypertension. Sanderson et al described the
transforming growth factor-	 (TGF-	) transgenic mousesome combination of the two. During the synthesis of
type I collagen the amino- and carboxy-propeptide do- (the TGF-	 transgene was expressed only in the liver,
driven by the murine albumin promoter and enhancer)mains are cleaved from the procollagens prior to the
mature collagen molecule assembling into collagen fi- [49]. Two of the mouse lines derived from this transgene
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exhibited renal disease. Histologically they developed animals in this study suggest that oim/oim mice with
mesangial expansion and thickened capillary loops, sug- kidney scores of 3 or less do not yet exhibit significant
gesting that chronically elevated circulating levels of changes in blood urea nitrogen (BUN) and creatinine
TGF-	 induces progressive glomerulosclerosis [50]. In levels. However, one of three oim/oim mice with the
this model initial glomerular abnormalities included mes- kidney score 4 (glomerular collagen area  38,372 m2)
angial expansion and interposition when podocyte mor- from which clinical chemistry analytes were measured had
phological features were intact, suggesting the glomeru- a moderately elevated BUN (35 vs. mean BUN of 22 for
lar mesangium is the major target of the circulating 14 other oim/oim mice; creatinine was not elevated in this
TGF-	. Immunostaining revealed increased type I and mouse; data not shown). Further studies are necessary
III collagens in the mesangium, glomerular capillary to determine the pathological significance of the type I
loops and interstitium, while type IV collagen was un- collagen accumulation in the glomeruli and whether it
changed. The increased collagen expression was due to is progressive.
increased mRNA (started as early as one week of age, This model, to our knowledge, represents the first ex-
prior to the appearance of glomerulosclerosis), and there ample of a specific type I collagen defect resulting in a
was evidence of increased matrix protein production and renal disease. Further studies in vivo and in vitro are
decreased matrix remodeling [51]. TGF-	 is known to necessary to elucidate the mechanistic, functional, and
be a bifunctional growth regulator in mesangial cells, pathological significance of the oim/oim collagen glomer-
stimulating collagens type I, IV, and fibronectin expres- ulopathy. Knowledge of the mesangial cell collagen phe-
sion [51, 52]. TGF-	 also may regulate matrix turnover notype during normal and diseased (pathologic) condi-
by increased expression of the tissue inhibitor of metallo- tions is essential for understanding the mechanisms
proteinase-1 (TIMP-1) renal tissue inhibitor of metallo- involved in the progression of glomerulosclerosis and
proteinase-1 (also known to inhibit all MMP family mem- the role played by mesangial cells in this process. The
bers) [51]. Francki et al demonstrated in cultured oim mouse offers a superb model system not only for
mesangial cells from the SPARC (secreted protein acidic examining the tissue specific role of type I collagen and
and rich in cysteine)-null mouse that in the absence of more specifically the functional necessity of the 2(I)
SPARC there was a significant reduction in type I colla- chain, but also for evaluating the role of pro2(I)collagen
gen mRNA and protein, which correlated with a signifi- in the regulation of collagen expression in the glomerular
cant reduction in TGF-	1 mRNA and secreted TGF-	1 mesangial cell.
protein [53]. Their findings suggest that in murine mesan-
gial cells, SPARC is essential to type I collagen expres- ACKNOWLEDGMENTS
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